alogliptin

Generic: alogliptin

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name alogliptin
Generic Name alogliptin
Labeler padagis israel pharmaceuticals ltd
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

alogliptin benzoate 25 mg/1

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-150
Product ID 45802-150_1287590b-abdf-470b-a611-dfb9bc93692a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA022271
Listing Expiration 2026-12-31
Marketing Start 2016-04-08

Pharmacologic Class

Classes
dipeptidyl peptidase 4 inhibitor [epc] dipeptidyl peptidase 4 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802150
Hyphenated Format 45802-150

Supplemental Identifiers

RxCUI
1368006 1368018 1368034
UPC
0345802087652 0345802103659 0345802150653
UNII
EEN99869SC

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alogliptin (source: ndc)
Generic Name alogliptin (source: ndc)
Application Number NDA022271 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (45802-150-65)
source: ndc

Packages (1)

45802-150-65 30 TABLET, FILM COATED in 1 BOTTLE (45802-150-65)

Ingredients (1)

alogliptin benzoate (25 mg/1)

Linked Drug Pages (1)

Alogliptin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1287590b-abdf-470b-a611-dfb9bc93692a", "openfda": {"upc": ["0345802087652", "0345802103659", "0345802150653"], "unii": ["EEN99869SC"], "rxcui": ["1368006", "1368018", "1368034"], "spl_set_id": ["b25f155a-1259-47c2-aa3b-7c1356e4c7f6"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (45802-150-65)", "package_ndc": "45802-150-65", "marketing_start_date": "20160408"}], "brand_name": "Alogliptin", "product_id": "45802-150_1287590b-abdf-470b-a611-dfb9bc93692a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "product_ndc": "45802-150", "generic_name": "Alogliptin", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alogliptin", "active_ingredients": [{"name": "ALOGLIPTIN BENZOATE", "strength": "25 mg/1"}], "application_number": "NDA022271", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20160408", "listing_expiration_date": "20261231"}